|1.||Lee, Hyo-Jung: 2 articles (09/2008 - 06/2007)|
|2.||Kim, Sung-Hoon: 2 articles (09/2008 - 06/2007)|
|3.||Ahn, Kyoo-Seok: 1 article (09/2008)|
|4.||Ahn, Kwang Seok: 1 article (09/2008)|
|5.||Park, Min-Jong: 1 article (09/2008)|
|6.||Kwon, Hee-Young: 1 article (09/2008)|
|7.||Lee, Eun-Ok: 1 article (09/2008)|
|8.||Kim, Cheol-Ho: 1 article (09/2008)|
|9.||Kim, Myung Ok: 1 article (09/2008)|
|10.||Celik, Yusuf: 1 article (05/2008)|
|1.||Myeloid Leukemia (Leukemia, Myelocytic)
09/26/2008 - "Thus, to elucidate the apoptotic mechanism of DMNQ-S17, this study was performed in myeloid leukemia U937 cells by 2,3-bis [2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) assay, eletrophoretic mobility shift assay (EMSA), terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) assay, 4',6-diamidino-2-phenylindole (DAPI) staining, and Western blotting. "
09/26/2008 - "Taken together, these findings suggest that DMNQ-S17 can be a potent anticancer candidate for myeloid leukemias by the suppression of NF-kappaB activation leading to the activation of caspase-3 in human myeloid leukemia U937 cells."
09/26/2008 - "DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells."
|2.||Lung Neoplasms (Lung Cancer)
|3.||Sarcoma (Soft Tissue Sarcoma)
|1.||DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
|3.||Caspase 3 (Caspase-3)
|4.||NF-kappa B (NF-kB)